Abstract
Circulating biomarkers have become a promising modality in the management of many cancers. Similarly, in breast cancer, circulatory biomarkers are useful, non-invasive methods in the diagnosis, prognostication, and evaluation of response to treatment. Invasive surgical biopsies can be potentially replaced by “liquid biopsy,” which involves analysing circulatory biomarkers that may reveal features of primary and metastatic disease. Therefore, providing an insight into the cancer biology can be utilised to monitor treatment response, treatment-induced adaptation and tumour and disease progression through non-invasive means. The objective of this review is to provide an overview of the current status of the circulating biomarkers highlighting their promising impact on the management of patients with breast cancer.
Keywords: Biomarkers, Breast cancer, Circulatory biomarkers, Diagnosis, Prognostication, Liquid biopsy.
Related Books
Industrial Applications of Soil Microbes
Industrial Applications of Soil Microbes
Biopolymers Towards Green and Sustainable Development
Algal Biotechnology for Fuel Applications
The Wax Moth: A Problem or a Solution?
Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases
An Introduction to Mycosporine-Like Amino Acids
Bioremediation for Environmental Pollutants
Bioremediation for Environmental Pollutants
Steroids and their Medicinal Potential